Jeremy Dennison is a Physician Scientist with a background in Infectious Diseases having gained a masters and PhD in the immunology of cerebral malaria from the Liverpool School of Tropical Medicine. He is also an experienced clinical pharmacologist and clinical development specialist having recently served as a clinical lead on the GSK team that brought the novel antibiotic gepotidacin to successful approval.